Document and Entity Information	6 Months Ended
Document and Entity Information	Jul. 31, 2014	Sep. 08, 2014
Document And Entity Information
Entity Registrant Name	MamaMancini's Holdings, Inc.
Entity Central Index Key	0001520358
Document Type	10-Q
Document Period End Date	Jul. 31, 2014
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		25,807,376
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2015

Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets (USD $)	Jul. 31, 2014	Jan. 31, 2014
Assets:
Cash	$ 114,774	$ 1,541,640
Accounts receivable, net	1,054,172	1,029,632
Inventories	469,158	159,829
Prepaid expenses	181,615	140,511
Due from manufacturer - related party	740,183	774,049
Deposit with manufacturer - related party	1,220,221	598,987
Total current assets	3,780,123	4,244,648
Property and equipment, net	1,142,295	978,027
Debt issuance costs, net	52,317	46,264
Total Assets	4,974,735	5,268,939
Liabilities:
Accounts payable and accrued expenses	417,853	595,297
Line of credit	293,341	222,704
Total current liabilities	711,194	818,001
Commitments and contingencies
Stockholders' Equity
Preferred stock, $0.00001 par value; 20,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.00001 par value; 250,000,000 shares authorized; 25,807,376 and 24,187,375 shares issued and outstanding, respectively	258	242
Additional paid in capital	12,300,854	10,993,973
Common stock subscribed, $0.00001 par value; 66,667 and 833,333 shares, respectively	1	8
Accumulated deficit	(8,037,572)	(6,543,285)
Total Stockholders' Equity	4,263,541	4,450,938
Total Liabilities and Stockholders' Equity	$ 4,974,735	$ 5,268,939

Condensed Consolidated Balance Sheets (Parenthetical)

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	25,807,376	24,187,375
Common stock, shares outstanding	25,807,376	24,187,375
Common stock subscribed, par value	$ 0.00001	$ 0.00001
Common stock subscribed, shares	66,667	833,333

Condensed Consolidated Statements of Operations

Condensed Consolidated Statements of Operations (USD $)	1 Months Ended	3 Months Ended		6 Months Ended
Condensed Consolidated Statements of Operations (USD $)	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Jul. 31, 2014	Jun. 30, 2013
Income Statement [Abstract]
Sales - net of slotting fees and discounts	$ 775,252	$ 2,249,768	$ 1,700,388	$ 4,832,917	$ 3,472,552
Cost of sales	535,870	1,590,904	1,185,886	3,371,129	2,467,988
Gross profit	239,382	658,864	514,502	1,461,788	1,004,564
Operating expenses
Research and development	8,477	24,091	3,995	42,992	7,138
General and administrative expenses	472,023	1,401,461	1,262,054	2,869,739	2,358,111
Total operating expenses	480,500	1,425,552	1,266,049	2,912,731	2,365,249
Loss from operations	(241,118)	(766,688)	(751,547)	(1,450,943)	(1,360,685)
Other income (expenses)
Interest expense	(2,526)	(26,710)	(1,525)	(43,344)	(3,775)
Total other income (expense)	(2,526)	(26,710)	(1,525)	(43,344)	(3,775)
Net loss	$ (243,644)	$ (793,398)	$ (753,072)	$ (1,494,287)	$ (1,364,460)
Net loss per common share - basic and diluted	$ (0.01)	$ (0.03)	$ (0.04)	$ (0.06)	$ (0.07)
Weighted average common shares outstanding - basic and diluted	24,187,375	25,452,943	20,854,000	25,091,224	20,747,923

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Common Stock Subscribed [Member]	Accumulated Deficit [Member]	Total
Balance at Jan. 31, 2014	$ 242	$ 10,993,973	$ 8	$ (6,543,285)	$ 4,450,938
Balance, shares at Jan. 31, 2014	24,187,375
Stock options issued for services		159,181			159,181
Warrants issued for services		188,900			188,900
Common stock issued	16	1,179,995	(8)		1,180,003
Common stock issued, shares	1,620,001
Common stock subscribed , 66,667 shares		99,999	1		100,000
Stock issuance costs		(321,194)
Net loss				(1,494,287)	(1,494,287)
Balance at Jul. 31, 2014	$ 258	$ 12,300,854	$ 1	$ (8,037,572)	$ 4,263,541
Balance, shares at Jul. 31, 2014	25,807,376

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) (Parenthetical)

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) (Parenthetical)	Jul. 31, 2014	Jan. 31, 2014	Jun. 30, 2013
Statement of Stockholders' Equity [Abstract]
Common stock subscribed, shares	66,667	833,333

Condensed Consolidated Statements of Cash Flows

Condensed Consolidated Statements of Cash Flows (USD $)	1 Months Ended	6 Months Ended
Condensed Consolidated Statements of Cash Flows (USD $)	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (243,644)	$ (1,494,287)	$ (1,364,460)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	4,141	59,473	9,752
Amortization of debt issuance costs	1,322	8,431
Share-based compensation	2,015	176,100	156,104
(Increase) Decrease in:
Accounts receivable	34,217	(24,540)	(180,976)
Inventory	(47,550)	(309,329)	(14,474)
Prepaid expenses	(4,986)	(41,104)	(69,315)
Due from manufacturer - related party	7,472	33,866	(218,708)
Deposit with manufacturer - related party	(239,481)	(621,234)	108,729
Increase (Decrease) in:
Accounts payable and accrued expenses	(227,747)	(177,444)	1,478
Due to manufacturer - related party
Net Cash Used In Operating Activities	(714,241)	(2,390,068)	(1,571,870)
CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for machinery and equipment	(52,672)	(223,741)	(77,037)
Cash paid for acquisition of shell company			(295,000)
Loans to related party			(30,000)
Net Cash Used In Investing Activities	(52,672)	(223,741)	(402,037)
CASH FLOWS FROM FINANCING ACTIVITIES:
Stock issuance costs	(58,500)	(149,213)
Proceeds from issuance of common stock		1,180,003
Proceeds from common stock subscribed	450,000	100,000
Debt issuance costs	(47,586)	(14,484)
Borrowings from line of credit, net	222,704	70,637	150,000
Net Cash Provided By Financing Activities	566,618	1,186,943	150,000
Net Decrease in Cash	(200,295)	(1,426,866)	(1,823,907)
Cash - Beginning of Period	1,741,935	1,541,640	2,008,161
Cash - End of Period	1,541,640	114,774	184,254
Cash Paid During the Period for:
Income taxes
Interest	8,640	43,344	3,775
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock issuance costs paid in the form of warrants	$ 43,166	$ 171,981	$ 213,971

Nature of Operations and Basis of Presentation

6 Months Ended

Jul. 31, 2014

Nature Of Operations And Basis Of Presentation

Nature of Operations and Basis of Presentation

Note 1 - Nature of Operations and Basis of Presentation

Nature of Operations

MamaMancini’s Holdings, Inc. (the “Company”), (formerly known as Mascot Properties, Inc.) was organized on July 22, 2009 as a Nevada corporation.

Current Business of the Company

The Company is a manufacturer and distributor of beef meatballs with sauce, turkey meatballs with sauce, and other similar meats and sauces. The Company’s customers are located throughout the United States, with a large concentration in the Northeast and Southeast.

Mergers

On January 24, 2013, the Company, Mascot Properties Acquisition Corp, a Delaware corporation and wholly-owned subsidiary of the Company (“Merger Sub”), MamaMancini’s, Inc., a privately-held Delaware Corporation headquartered in New Jersey (“MamaMancini’s”) and an individual (the “Majority Shareholder”), entered into an Acquisition Agreement and Plan of Merger (the “Agreement”) pursuant to which the Merger Sub was merged with and into MamaMancini’s, with MamaMancini’s surviving as a wholly-owned subsidiary of the Company (the “Merger”). The Company acquired, through a reverse triangular merger, all of the outstanding capital stock of MamaMancini’s in exchange for issuing MamaMancini’s shareholders (the “MamaMancini’s Shareholders”), pro-rata, a total of 20,054,000 shares of the Company’s common stock. Immediately after the Merger was consummated, and further to the Agreement, the majority shareholders and certain affiliates of the Company cancelled a total of 103,408,000 shares of the Company’s common stock held by them (the “Cancellation”). In consideration of the Cancellation of such common stock, the Company paid the Majority Shareholder in aggregate of $295,000 and 800,000 shares of common stock and released the other affiliates from certain liabilities. In addition, the Company has agreed to spinout to the Majority Shareholder all assets related to the Company’s real estate management business within 30 days after the closing. As a result of the Merger and the Cancellation, the MamaMancini’s Shareholders became the majority shareholders of the Company.

The condensed consolidated financial statements presented for all periods through and including July 31, 2014 are those of MamaMancini’s. As a result of this Merger, the equity sections of MamaMancini’s for all prior periods presented reflect the recapitalization described above and are consistent with the July 31, 2014 balance sheet presented for the Company.

Since the transaction is considered a reverse acquisition and recapitalization, the presentation of pro-forma financial information was not required.

Basis of Presentation

The condensed consolidated financial statements and related notes have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) and include the accounts of the Company and its wholly-owned subsidiaries. All material intercompany balances and transactions have been eliminated in consolidation.

The unaudited financial information furnished herein reflects all adjustments, consisting solely of normal recurring items, which in the opinion of management are necessary to fairly state the financial position of the Company and the results of its operations for the periods presented. This report should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year ended December 31, 2013 filed on March 20, 2014 and the audited financial statements as of January 31, 2014 and for the one month period then ended filed with this Form 10-Q. The Company assumes that the users of the interim financial information herein have read or have access to the audited financial statements for the preceding fiscal year and that the adequacy of additional disclosure needed for a fair presentation may be determined in that context. Accordingly, footnote disclosure, which would substantially duplicate the disclosure contained in the Company’s Form 10-K for the year ended December 31, 2013 have been omitted. The results of operations for the interim periods presented are not necessarily indicative of results for the entire year ending January 31, 2015.

Summary of Significant Accounting Policies

6 Months Ended

Jul. 31, 2014

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

Change of Year End

Effective January 13, 2014, MamaMancini’s Holdings, Inc. (the “Company”) changed its fiscal year-end date to January 31. The Company’s 2014 fiscal year commenced on February 1, 2014 and concludes on January 31, 2015. The Company changed its year end to be consistent with a significant number of its retail customers that have a fiscal year end on or near January 31. This allows the Company to more accurately account for accrued discounts and promotions to these retailers. The Company determined that recasting the prior year comparable period ended January 31, 2013 would not be material.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such estimates and assumptions impact, among others, the following: allowance for bad debt, inventory obsolescence, the fair value of share-based payments.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

Risks and Uncertainties

The Company operates in an industry that is subject to intense competition and change in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks including the potential risk of business failure.

The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the grocery industry, (ii) general economic conditions in the various local markets in which the Company competes, including the general downturn in the economy, and (iii) the volatility of prices pertaining to food and beverages in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

Cash

The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents. The Company held no cash equivalents at July 31, 2014 or January 31, 2014.

The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.

Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are stated at the amount management expects to collect from outstanding balances. The Company generally does not require collateral to support customer receivables. The Company provides an allowance for doubtful accounts based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. The Company determines if receivables are past due based on days outstanding, and amounts are written off when determined to be uncollectible by management. The maximum accounting loss from the credit risk associated with accounts receivable is the amount of the receivable recorded, which is the face amount of the receivable net of the allowance for doubtful accounts. As of July 31, 2014 and January 31, 2014, the Company had reserves of $2,000.

Inventories

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at July 31, 2014 and January 31, 2014:

	July 31, 2014		January 31, 2014
Finished goods	$	469,158	$	159,829

Property and Equipment

Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives.

Asset lives for financial statement reporting of depreciation are:

Machinery and equipment		2-7 years
Furniture and fixtures		3-5 years
Leasehold improvements		3-10 years

Fair Value of Financial Instruments

For purpose of this disclosure, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced sale or liquidation. The carrying amount of the Company’s short term financial instruments approximates fair value due to the relatively short period to maturity for these instruments.

Stock Issuance Costs

Stock issuance costs are capitalized as incurred. Upon the completion of the offering, the stock issuance costs are reclassified to equity. Offering costs recorded to equity for the six months ended July 31, 2014 and June 30, 2013 and the one month ended January 31, 2014 were $321,194, $0 and $102,166, respectively.

Research and Development

Research and development is expensed as incurred. Research and development expenses for three months ended July 31, 2014 and June 30, 2013 were $24,091 and $3,995, respectively. Research and development expenses for six months ended July 31, 2014 and June 30, 2013 and the one month ended January 31, 2014 were $42,992, $7,138 and $8,477, respectively.

Shipping and Handling Costs

The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales.

Revenue Recognition

The Company records revenue for products when all of the following have occurred: (1) persuasive evidence of an arrangement exists, (2) the product is delivered, (3) the sales price to the customer is fixed or determinable, and (4) collectability of the related customer receivable is reasonably assured. There is no stated right of return for products.

The Company meets these criteria upon shipment.

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

	Six Months Ended July 31, 2014		Six Months Ended June 30, 2013		One Month Ended January 31, 2014
Gross Sales	$	5,021,325	$	3,716,948	$	796,177
Less: Slotting, Discounts, Allowances		188,408		244,396		20,925
Net Sales	$	4,832,917	$	3,472,552	$	775,252

Cost of Sales

Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.

Advertising

Costs incurred for producing and communicating advertising for the Company are charged to operations as incurred. Producing and communicating advertising expenses for the three months ended July 31, 2014 and June 30, 2013 were $549,560 and $393,722, respectively. Producing and communicating advertising expenses for the six months ended July 31, 2014 and June 30, 2013 and the one month ended January 31, 2014 were $1,265,859, $810,722 and $232,481, respectively.

Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Accounting for Stock-Based Compensation” (“ASC 718”) which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value based method of accounting for an employee stock option or similar equity instrument. The Company accounts for compensation cost for stock option plans in accordance with ASC 718. The Company accounts for share-based payments to non-employees in accordance with ASC 505-50 “Accounting for Equity Instruments Issued to Non-Employees for Acquiring, or in Conjunction with Selling Goods or Services”.

The Company recognizes all forms of share-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest.

Share-based payments, excluding restricted stock, are valued using a Black-Scholes option pricing model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Stock-based compensation expenses are included in cost of goods sold or selling, general and administrative expenses, depending on the nature of the services provided, in the Condensed Consolidated Statement of Operations.

For the three months ended July 31, 2014 and June 30, 2013 share-based compensation amounted to $248,982 and $156,104, respectively. For the six months ended July 31, 2014 and June 30, 2013 and the one month ended January 31, 2014 share-based compensation amounted to $348,081, $156,104 and $45,681, respectively. Of the $348,081 recorded for the six months ended July 31, 2014, $171,974 was a direct cost of a stock offering and has been recorded as a reduction in additional paid in capital.

For the six months ended July 31, 2014, when computing fair value of share-based payments, the Company has considered the following variables:

●	The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.26%-1.76%.

●	The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was 0%.

●	The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

●	The warrant term is the life of the warrant.

●	The expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 144%-193%.

●	The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%.

Earnings Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during each period. Diluted earnings (loss) per share is computed by dividing net income (loss), adjusted for changes in income or loss that resulted from the assumed conversion of convertible shares, by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period.

The Company had the following potential common stock equivalents at July 31, 2014:

Common stock subscribed			66,667
Common stock warrants, exercise price range of $1.00-$1.50			1,111,401
Common stock options, exercise price of $1.00-$2.97			564,404
Total common stock equivalents			1,742,472

The Company had the following potential common stock equivalents at June 30, 2013:

Common stock subscribed			--
Common stock warrants, exercise price range of $1.00			505,400
Common stock options, exercise price of $1.00			491,404
Total common stock equivalents			996,804

Since the Company reflected a net loss during the three and six months ended July 31, 2014 and June 30, 2013, the effect of considering any common stock equivalents, would have been anti-dilutive. A separate computation of diluted earnings (loss) per share is not presented.

Income Taxes

Income taxes are provided in accordance with ASC No. 740, “Accounting for Income Taxes”. A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards. Deferred tax expense (benefit) results from the net change during the period of deferred tax assets and liabilities.

Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

Recent Accounting Pronouncements

The U.S. Financial Accounting Standards Board issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers, in May 2014. The amendments in this Update supersede the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification. In addition, the amendments supersede the cost guidance in Subtopic 605-35, Revenue Recognition—Construction-Type and Production-Type Contracts, and create new Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers. In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This Accounting Standards Update is the final version of Proposed Accounting Standards Update 2011-230—Revenue Recognition (Topic 605) and Proposed Accounting Standards Update 2011–250—Revenue Recognition (Topic 605): Codification Amendments, both of which have been deleted. Accounting Standards Update 2014-09. The amendments in this Update are effectively for the Company for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. The Company is currently evaluating the effects of ASU 2014-09 on the condensed consolidated financial statements.

In June 2014, the Financial Accounting Standards Board issued Accounting Standards Update 2014-12, Compensation- Stock Compensation. The amendments in this update apply to reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target can be achieved after the requisite service period. This Accounting Standards Update is the final version of Proposed Accounting Standards Update EITF-13D—Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, which has been deleted. The proposed amendments would apply to reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target could be achieved after the requisite service period. This Accounting Standards Update is the final version of Proposed Accounting Standards Update EITF-13D—Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period, which has been deleted. The amendments in this Update are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, and early adoption is permitted. The Company is currently evaluating the effects of ASU 2014-12 on the condensed consolidated financial statements.

Property and Equipment

6 Months Ended

Jul. 31, 2014

Property, Plant and Equipment [Abstract]

Property and Equipment

Note 3 - Property and Equipment:

Property and equipment on July 31, 2014 and January 31, 2014 are as follows:

	July 31, 2014		January 31, 2014
Machinery and Equipment	$	1,034,943	$	1,027,431
Furniture and Fixtures		14,672		4,525
Leasehold Improvements		208,814		2,733
		1,258,430		1,034,689
Less: Accumulated Depreciation		116,135		56,662
	$	1,142,295	$	978,027

At January 31, 2014, fixed assets in the amount of $826,340 were not in service.

Depreciation expense charged to income for the three months ended July 31, 2014 and June 30, 2013 amounted to $44,736 and $6,492, respectively. Depreciation expense charged to income for the six months ended July 31, 2014 and June 30, 2013 and the one month ended January 31, 2014 amounted to $59,473, $9,752 and $4,141, respectively.

Investment in Meatball Obsession, LLC

6 Months Ended

Jul. 31, 2014

Investments in and Advances to Affiliates, Schedule of Investments [Abstract]

Investment in Meatball Obsession, LLC

Note 4 - Investment in Meatball Obsession, LLC

During 2011 the Company acquired a 34.62% interest in Meatball Obsession, LLC (“MO”) for a total investment of $27,032. This investment is accounted for using the equity method of accounting. Accordingly, investments are recorded at acquisition cost plus the Company’s equity in the undistributed earnings or losses of the entity.

At December 31, 2011 the investment was written down to $0 due to losses incurred by MO.

During 2013 the Company’s ownership interest in MO fell to 24% due to dilution.

During the six months ended July 31, 2014 the Company’s ownership interest in MO fell to 13% due to dilution.

Related Party Transactions

6 Months Ended

Jul. 31, 2014

Related Party Transactions

Note 5 - Related Party Transactions

Supply Agreement

On March 1, 2010, the Company entered into a five year agreement with a Manufacturer (the “Manufacturer”) who is a related party. The Manufacturer is owned by the CEO and President of the Company. Under the terms of the agreement, the Company grants to the Manufacturer a revocable license to use the Company’s recipes, formulas, methods and ingredients for the preparation and production of Company’s products, for manufacturing the Company’s product and all future improvements, modifications, substitutions and replacements developed by the Company. The Manufacturer in turn grants the Company the exclusive right to purchase the product. Under the terms of the agreement the Manufacturer agrees to manufacture, package, and store the Company’s products and the Company has the right to purchase products from one or more other manufacturers, distributors or suppliers. The agreement contains a perpetual automatic renewal clause for a period of one year after the expiration of the initial term. During the renewal period either party may cancel the contract with written notice nine months prior to the termination date.

Under the terms of the agreement if the Company specifies any change in packaging or shipping materials which results in the manufacturer incurring increased expense for packaging and shipping materials or in the Manufacturer being unable to utilize obsolete packaging or shipping materials in ordinary packaging or shipping, the Company agrees to pay as additional product cost the additional cost for packaging and shipping materials and to purchase at cost such obsolete packaging and shipping materials. If the Company requests any repackaging of the product, other than due to defects in the original packaging, the Company will reimburse the Manufacturer for any labor costs incurred in repackaging. Per the agreement, all product delivery shipping costs are the expense of the Company.

During the three and six months ended July 31, 2014 and June 30, 2013, the Company purchased substantially all of its inventory from the Manufacturer. At July 31, 2014 and January 31, 2014, the Company has a deposit on inventory in the amount of $1,220,221 and $598,987, respectfully, to this Manufacturer.

Meatball Obsession, LLC

A current director of the Company is the chairman of the board and shareholder of Meatball Obsession LLC.

Due from Manufacturer – Related Party

During the three and six months ended July 31, 2014 and June 30, 2013, the Manufacturer received payments on behalf of the Company for the Company’s customer invoices and the Manufacturer incurred expenses on behalf of the Company for shared administrative expenses and salary expenses. In addition the Company made several unsecured loans to the Manufacturer during 2013. The loan to the Manufacturer is unsecured, does not bear interest and is due on demand. At July 31, 2014 and January 31, 2014 the amount due from the Manufacturer is as follows:

	July 31, 2014			January 31, 2014
Customer receipts collected by Manufacturer on behalf of Company	$	575,255		$	575,255
Loan to Manufacturer		450,000			450,000
Shared expenses paid by Manufacturer on behalf of the Company		(285,072	)		(251,206	)
Due from Manufacturer	$	740,183		$	774,049

Line of Credit

6 Months Ended

Jul. 31, 2014

Debt Disclosure [Abstract]

Line of Credit

Note 6 - Line of Credit

Effective January 3, 2014, the Company entered into a Sale and Security Agreement (the “Sale and Security Agreement”) with Faunus Group International, Inc. (“FGI”) to provide for a $1.5 million secured demand credit facility backed by its receivables and inventory (the “FGI Facility”). The Sale and Security Agreement has an initial three year term (the “Original Term”) and shall be extended automatically for an additional one year for each succeeding term unless written notice of termination is given by either party at least sixty days prior to the end of the Original Term or any extension thereof. The Company and certain of its affiliates also entered into guarantees to guarantee the performance of the obligations under the Sale and Security Agreement (the “Guaranty Agreements”). The Company also granted FGI a security interest in and lien upon all of the Company’s right, title and interest in and to all of its assets (as defined in the Sale and Security Agreement).

Pursuant to the FGI Facility, FGI can elect to purchase eligible accounts receivables (“Purchased Accounts”) up to 70% of the value of such receivables (retaining a 30% reserve). At FGI’s election, FGI may advance the Company up to 70% of the value of any Purchased Accounts, subject to the FGI Facility. Reserves retained by FGI on any Purchased Accounts are expected to be refunded to the Company net of interest and fees on advances once the receivables are collected from customers. The interest rate on advances or borrowings under the FGI Facility will be the greater of (i) 6.75% per annum and (ii) 2.50% above the prime rate. Any advances or borrowings under the FGI Facility are due on demand.

The Company also agreed to pay to FGI monthly collateral management fees of 0.42% of the average monthly balance of Purchased Accounts. The minimum monthly net funds employed during each contract year hereof shall be $500,000. Additionally, the Company paid FGI a one-time facility fee equal to 1% of the FGI Facility upon entry into the Sale and Security Agreement.

Subsequent to July 31, 2014, the Company terminated its agreement with FGI and paid off all obligations due at the payoff date. Upon termination, the Company, additional fees and accrued interest of approximately $48,600 were paid.

On September 3, 2014, the Company entered into a new loan and security agreement with Entrepreneur Growth Capital (“EGC”). See Note 10.

Concentrations

6 Months Ended

Jul. 31, 2014

Risks and Uncertainties [Abstract]

Concentrations

Note 7 - Concentrations

Revenues

During the six months ended July 31, 2014, the Company earned revenues from three customers representing approximately 23%, 17% and 11% of gross sales. During the six months ended June 30, 2013, the Company earned revenues from five customers representing approximately 23%, 16%, 15%, 10% and 10% of gross sales. During the one month ended January 31, 2014, three customers represented 18%, 15% and 10% of gross sales.

Cost of Sales

For the six months ended July 31, 2014 and June 30, 2013 and the one month ended January 31, 2014, one vendor (a related party) represented 100% of the Company’s purchases.

Accounts Receivable

As of July 31, 2014, two customers represented approximately 21% and 13% of total gross accounts receivable. As of January 31, 2014, one customer represented approximately 24% of total gross accounts receivable.

Stockholders' Equity

6 Months Ended

Jul. 31, 2014

Equity [Abstract]

Stockholders' Equity

Note 8 - Stockholders’ Equity

(A)

Common Stock Transactions

During January 2014, the Company sold 300,000 shares of common stock to investors in exchange for $450,000 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in March 2014.

In connection with the private placement the Company incurred fees of $102,166 consisting of $58,500 in cash and 30,000 warrants with a fair value of $43,666.

During March 2014, the Company sold 236,667 shares of common stock to investors in exchange for $355,000 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in June 2014.

In connection with the private placement the Company incurred fees of $80,536 consisting of $46,150 in cash and 23,667 warrants with a fair value of $34,386.

During April 2014, the Company sold 416,668 shares of common stock to investors in exchange for $625,001 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in June 2014.

In connection with the private placement the Company incurred fees of $141,791 consisting of $81,250 in cash and 41,667 warrants with a fair value of $60,541.

During May 2014, the Company sold 133,333 shares of common stock to investors in exchange for $200,000 in proceeds in connection with the private placement of the Company’s stock. The shares were issued in June 2014.

In connection with the private placement the Company incurred fees of $82,796 consisting of $26,000 in cash and 17,333 warrants with a fair value of $56,796.

Common Stock Subscribed

During June 2014, the Company sold 66,668 shares of common stock to investors in exchange for $100,000 in proceeds in connection with the private placement of the Company’s stock. The shares were not issued as of July 31, 2014.

In connection with the private placement the Company incurred fees of $33,258 consisting of $13,000 in cash and 8,667 warrants with a fair value of $20,258.

(B) Options

The following is a summary of the Company’s option activity:

	Options			Weighted Average Exercise Price

Outstanding – January 1, 2013		223,404		$	1.00
Exercisable – January 1, 2013		-		$	-
Granted		318,000		$	1.00
Exercised		-		$	-
Forfeited/Cancelled		-		$	-
Outstanding – December 31, 2013		541,404		$	1.00
Exercisable – December 31, 2013		428,845		$	1.00
Granted		-		$	-
Exercised		-		$	-
Forfeited/Cancelled		-		$	-
Outstanding – January 31, 2014		541,404		$	1.00
Exercisable – January 31, 2014		434,177		$	1.00
Granted		59,000		$	2.95
Exercised		-		$	-
Forfeited/Cancelled		(36,000	)	$	-
Outstanding – July 31, 2014		564,404		$	1.20
Exercisable – July 31, 2014		472,404		$	1.22

Options Outstanding							Options Exercisable
Range of Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

$	1.00		505,404	3.52 years	$	1.00		417,904	$	1.00
$	2.95		50,000	4.73 years	$	2.95		50,000	$	2.95
$	2.97		9,000	4.75 years	$	2.97		4,500	$	2.97

At July 31, 2014 and January 31, 2014, the total intrinsic value of options outstanding and exercisable was $429,593 and $1,082,808, respectively.

As of July 31, 2014, the Company has $84,351 in stock-based compensation related to stock options that is yet to be vested. The weighted average expensing period of the unvested options is 1.48 years.

(C) Warrants

The following is a summary of the Company’s warrant activity:

	Warrants		Weighted Average Exercise Price

Outstanding – January 1, 2013		505,400	$	1.00
Exercisable – January 1, 2013		-	$	-
Granted		386,667	$	1.50
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – December 31, 2013		892,067	$	1.22
Exercisable – December 31, 2013		892,067	$	1.22
Granted		30,000	$	1.50
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – January 31, 2014		922,067	$	1.22
Exercisable – January 31, 2014		922,067	$	1.22
Granted		189,334	$	2.02
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – July 31, 2014		1,111,401	$	1.36
Exercisable – July 31, 2014		1,013,401	$	1.25

Warrants Outstanding						Warrants Exercisable
Range of Exercise Price		Number Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

	$1.00-$2.50	1,111,401	3.71 years	$	1.36		1,013,401	$	1.25

At July 31, 2014 and January 31, 2014, the total intrinsic value of warrants outstanding and exercisable was $607,390 and $1,635,801, respectively.

Commitments and Contingencies

6 Months Ended

Jul. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 9 - Commitments and Contingencies

Litigations, Claims and Assessments

From time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business. The Company is currently not aware of any such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse effect on its business, financial condition or operating results.

Licensing and Royalty Agreements

On March 1, 2010, the Company was assigned a Development and License agreement (the “Agreement”). Under the terms of the Agreement the Licensor shall develop for the Company a line of beef meatballs with sauce, turkey meatballs with sauce and other similar meats and sauces for commercial manufacture, distribution and sale (each a “Licensor Product” and collectively the “Licensor Products”). Licensor shall work with Licensee to develop Licensor Products that are acceptable to Licensee. Upon acceptance of a Licensor Product by Licensee, Licensor’s trade secret recipes, formulas methods and ingredients for the preparation and production of such Licensor Products (the “Recipes”) shall be subject to this Development and License Agreement.

The term of the Agreement (the “Term”) shall consist of the Exclusive Term and the Non-Exclusive Term. The 12-month period beginning on each January 1 and ending on each December 31 is referred to herein as an “Agreement Year.”

The Exclusive Term began on January 1, 2009 (the “Effective Date”) and ends on the 50th anniversary of the Effective Date, unless terminated or extended as provided herein. Licensor, at its option, may terminate the Exclusive Term by notice in writing to Licensee, delivered between the 60th and the 90th day following the end of any Agreement Year if, on or before the 60th day following the end of such Agreement Year, Licensee has not paid Licensor Royalties with respect to such Agreement Year at least equal to the minimum royalty (the “Minimum Royalty”) for such Agreement Year. Subject to the foregoing sentence, and provided Licensee has not breached this Agreement and failed to cure such breach in accordance herewith, Licensee may extend the Exclusive Term for an additional twenty five (25) years, by notice in writing to Licensor, delivered on or before the 50th anniversary of the Effective Date.

The Non-Exclusive Term begins upon expiration of the Exclusive Term and continues indefinitely thereafter, until terminated by Licensor due to a material breach hereof by Licensee that remains uncured after notice and opportunity to cure in accordance herewith, or until terminated by Licensee.

Either party may terminate this Agreement in the event that the other party materially breaches its obligations and fails to cure such material breach within sixty (60) days following written notice from the non-breaching party specifying the nature of the breach. The following termination rights are in addition to the termination rights provided elsewhere in the agreement

●

Termination by Licensee - Licensee shall have the right to terminate this Agreement at any time on sixty (60) days written notice to Licensor. In such event, all moneys paid to Licensor shall be deemed non-refundable.

Under the terms of the Agreement the Company is required to pay quarterly royalty fees as follows:

During the Exclusive Term and the Non-Exclusive Term the Company will pay a royalty equal to the royalty rate (the “Royalty Rate”), multiplied by Company’s “Net Sales”. As used herein, “Net Sales” means gross invoiced sales of Products, directly or indirectly to unrelated third parties, less (a) discounts (including cash discounts), and retroactive price reductions or allowances actually allowed or granted from the billed amount (collectively “Discounts”); (b) credits, rebates, and allowances actually granted upon claims, rejections or returns, including recalls (voluntary or otherwise) (collectively, “Credits”); (c) freight, postage, shipping and insurance charges; (d) taxes, duties or other governmental charges levied on or measured by the billing amount, when included in billing, as adjusted for rebates and refunds; and (e) provisions for uncollectible accounts determined in accordance with reasonable accounting methods, consistently applied.

The Royalty Rate shall be: 6% of net sales up to $500,000 of net sales for each Agreement year; 4% of Net Sales from $500,000 up to $2,500,000 of Net Sales for each Agreement year; 2% of Net Sales from $2,500,000 up to $20,000,000 of Net Sales for each Agreement year; and 1% of Net Sales in excess of $20,000,000 of Net Sales for each Agreement year.

In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows:

Agreement Year	Minimum Royalty to be Paid with Respect to Such Agreement Year
1^stand 2^nd	$	-
3^rdand 4^th	$	50,000
5^th, 6^th and 7^th	$	75,000
8^thand 9^th	$	100,000
10^thand thereafter	$	125,000

The Company incurred $37,096 and $47,006 of royalty expenses for the three months ended July 31, 2014 and June 30, 2013. The Company incurred $115,726, $118,122 and $35,551 of royalty expenses for the six months ended July 31, 2014 and June 30, 2013 and the one month ended January 31, 2014. Royalty expenses are included in general and administrative expenses on the Condensed Consolidated Statement of Operations.

Agreements with Placement Agents and Finders

(A)

December 1, 2011

The Company entered into a Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective December 1, 2011 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $6 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

Along with the above fees, the Company shall pay up to $40,000 for expenses incurred by Spartan in connection with this Financing, together with cost of background checks on the officers and directors of the Company.

During the year ended 2012 the Company paid to Spartan fees of $505,400 and issued Spartan 505,400 five year warrants with an exercise price of $1.00.

(B)

May 2, 2013

The Company entered into a second Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective May 2, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and up to 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0mil-$5.0mil) outlined in the Spartan Advisory Agreement. On October 29, 2013 the Company entered into an amendment to the Agreement and the $10,000 monthly fee was cancelled.

During the year ended December 31, 2013 the Company paid to Spartan fees of $650,000 and issued Spartan 333,333 five year warrants with an exercise price of $1.50.

(C)

October 22, 2013

The Company entered into a third Financial Advisory and Investment Banking Agreement with Spartan Capital Securities, LLC (“Spartan”) effective October 22, 2013 (the “Spartan Advisory Agreement”). Pursuant to the Spartan Advisory Agreement, Spartan will act, for a minimum of twenty-four months from the date of the agreement, as the Company’s exclusive financial advisor and placement agent to assist the Company in connection with a best efforts private placement (the “Financing”) of up to $2.5 million of the Company’s equity and/or debt securities and/or convertible instruments (the “Securities”).

The Company upon closing of the Financing shall pay consideration to Spartan, in cash, a fee in an amount equal to 10% of the aggregate gross proceeds raised in the Financing and 3% of the aggregate gross proceeds raised in the Financing for expenses incurred by Spartan. The Company shall grant and deliver to Spartan at the closing of the Financing, for nominal consideration, five year warrants (the “Warrants”) to purchase a number of shares of the Company’s Common Stock equal to 10% of the number of shares of Common Stock (and/or shares of Common Stock issuable upon exercise of securities or upon conversion or exchange of convertible or exchangeable securities) sold at such closing. The Warrants shall be exercisable at any time during the five year period commencing on the closing to which they relate at an exercise price equal to the purchase price per share of Common Stock paid by investors in the Financing or, in the case of exercisable, convertible, or exchangeable securities, the exercise, conversion or exchange price thereof. If the Financing is consummated by means of more than one closing, Spartan shall be entitled to the fees provided herein with respect to each such closing.

The Company shall pay to Spartan a non-refundable monthly fee of $10,000 for the term of the agreement. Such monthly fee shall survive any termination of the Agreement.

During the year ended December 31, 2013 the Company paid to Spartan financing fees of $104,000 and issued Spartan 53,333 five year warrants with an exercise price of $1.50.

During the month ended January 31, 2014 the Company paid to Spartan financing fees of $58,500 and issued Spartan 30,000 five year warrants with an exercise price of $1.50.

During the six months ended July 31, 2014, the Company paid to Spartan financing fees of $166,400 and issued Spartan 91,333 five year warrants with an exercise price of $1.50.

Subsequent Events

6 Months Ended

Jul. 31, 2014

Subsequent Events [Abstract]

Subsequent Events

Note 10 - Subsequent Events

On September 3, 2014, the Company entered into a Loan and Security Agreement (“Loan and Security Agreement”) with Entrepreneur Growth Capital, LLC (“EGC”). The total facility is for an aggregate $3,100,000. The facility consists of the following:

●	Accounts Revolving Line of Credit:	$	2,150,000
●	Inventory Revolving Line of Credit:	$	350,000
●	Term Loan Line of Credit:	$	600,000

The revolving interest rates is equal to the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus (a) 2.5% on loans and advances made against eligible accounts and (b) 4.0% on loans made against eligible inventory. The term loan bears interest at a rate of the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0%. The Company is required to pay a one time facility fee equal to 2.25% of the total $3,100,000 facility. In the event of default, the Company shall pay 10% above the stated rates of interest pursuant to the Loan and Security Agreement. The drawdowns are secured by specific assets of the Company.

In addition, on September 3, 2014, the Company entered into a 5 year $600,000 Secured Promissory Note (“EGC Note”) with EGC. The EGC Note is payable in 60 monthly installments of $10,000. The EGC Note bears interest at highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0% and is payable monthly, in arrears. In the event of default, the Company shall pay 10% above the stated rates of interest per the Loan and Security Agreement. The Note is secured by all assets of the Company.

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jul. 31, 2014

Accounting Policies [Abstract]

Change of Year End

Change of Year End

Use of Estimates

Use of Estimates

Risks and Uncertainties

Risks and Uncertainties

Cash

Cash

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

Inventories

Inventories

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at July 31, 2014 and January 31, 2014:

	July 31, 2014		January 31, 2014
Finished goods	$	469,158	$	159,829

Property and Equipment

Property and Equipment

Property and equipment are recorded at cost. Depreciation expense is computed using straight-line methods over the estimated useful lives.

Asset lives for financial statement reporting of depreciation are:

Machinery and equipment		2-7 years
Furniture and fixtures		3-5 years
Leasehold improvements		3-10 years

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Stock Issuance Costs

Stock Issuance Costs

Research and Development

Research and Development

Shipping and Handling Costs

Shipping and Handling Costs

The Company classifies freight billed to customers as sales revenue and the related freight costs as cost of sales.

Revenue Recognition

Revenue Recognition

The Company meets these criteria upon shipment.

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

	Six Months Ended July 31, 2014		Six Months Ended June 30, 2013		One Month Ended January 31, 2014
Gross Sales	$	5,021,325	$	3,716,948	$	796,177
Less: Slotting, Discounts, Allowances		188,408		244,396		20,925
Net Sales	$	4,832,917	$	3,472,552	$	775,252

Cost of Sales

Cost of Sales

Cost of sales represents costs directly related to the production and manufacturing of the Company’s products. Costs include product development, freight, packaging, and print production costs.

Advertising

Advertising

Stock-based Compensation

Stock-Based Compensation

For the six months ended July 31, 2014, when computing fair value of share-based payments, the Company has considered the following variables:

●	The risk-free interest rate assumption is based on the U.S. Treasury yield for a period consistent with the expected term of the option in effect at the time of the grant. The risk free rate used had a range of 0.26%-1.76%.

●	The Company has not paid any dividends on common stock since its inception and does not anticipate paying dividends on its common stock in the foreseeable future. Therefore the expected dividend rate was 0%.

●	The expected option term is computed using the “simplified” method as permitted under the provisions of Staff Accounting Bulletin (“SAB”) 110. The Company uses the simplified method to calculate expected term of share options and similar instruments as the Company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term.

●	The warrant term is the life of the warrant.

●	The expected volatility was benchmarked against similar companies in a similar industry. The expected volatility used had a range of 144%-193%.

●	The forfeiture rate is based on the historical forfeiture rate for the Company’s unvested stock options, which was 0%.

Earnings Per Share

Earnings Per Share

The Company had the following potential common stock equivalents at July 31, 2014:

Common stock subscribed			66,667
Common stock warrants, exercise price range of $1.00-$1.50			1,111,401
Common stock options, exercise price of $1.00-$2.97			564,404
Total common stock equivalents			1,742,472

The Company had the following potential common stock equivalents at June 30, 2013:

Common stock subscribed			--
Common stock warrants, exercise price range of $1.00			505,400
Common stock options, exercise price of $1.00			491,404
Total common stock equivalents			996,804

Income Taxes

Income Taxes

Recent Accounting Pronouncements

Recent Accounting Pronouncements

Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jul. 31, 2014

Accounting Policies [Abstract]

Schedule of Inventories

Inventories are stated at average cost using the first-in, first-out (FIFO) valuation method. Inventory was comprised of the following at July 31, 2014 and January 31, 2014:

	July 31, 2014		January 31, 2014
Finished goods	$	469,158	$	159,829

Schedule of Property and Equipment Estimated Useful Lives

Asset lives for financial statement reporting of depreciation are:

Machinery and equipment		2-7 years
Furniture and fixtures		3-5 years
Leasehold improvements		3-10 years

Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction

Expenses such as slotting fees, sales discounts, and allowances are accounted for as a direct reduction of revenues as follows:

	Six Months Ended July 31, 2014		Six Months Ended June 30, 2013		One Month Ended January 31, 2014
Gross Sales	$	5,021,325	$	3,716,948	$	796,177
Less: Slotting, Discounts, Allowances		188,408		244,396		20,925
Net Sales	$	4,832,917	$	3,472,552	$	775,252

Schedule of Common Stock Equivalents

The Company had the following potential common stock equivalents at July 31, 2014:

Common stock subscribed			66,667
Common stock warrants, exercise price range of $1.00-$1.50			1,111,401
Common stock options, exercise price of $1.00-$2.97			564,404
Total common stock equivalents			1,742,472

The Company had the following potential common stock equivalents at June 30, 2013:

Common stock subscribed			--
Common stock warrants, exercise price range of $1.00			505,400
Common stock options, exercise price of $1.00			491,404
Total common stock equivalents			996,804

Property and Equipment (Tables)

6 Months Ended

Jul. 31, 2014

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment

Property and equipment on July 31, 2014 and January 31, 2014 are as follows:

	July 31, 2014		January 31, 2014
Machinery and Equipment	$	1,034,943	$	1,027,431
Furniture and Fixtures		14,672		4,525
Leasehold Improvements		208,814		2,733
		1,258,430		1,034,689
Less: Accumulated Depreciation		116,135		56,662
	$	1,142,295	$	978,027

Related Party Transactions (Tables)

6 Months Ended

Jul. 31, 2014

Schedule of Amount Due from Manufacturer

At July 31, 2014 and January 31, 2014 the amount due from the Manufacturer is as follows:

	July 31, 2014			January 31, 2014
Customer receipts collected by Manufacturer on behalf of Company	$	575,255		$	575,255
Loan to Manufacturer		450,000			450,000
Shared expenses paid by Manufacturer on behalf of the Company		(285,072	)		(251,206	)
Due from Manufacturer	$	740,183		$	774,049

Stockholders' Equity (Tables)

6 Months Ended

Jul. 31, 2014

Equity [Abstract]

Summary of Option Activity

The following is a summary of the Company’s option activity:

	Options			Weighted Average Exercise Price

Outstanding – January 1, 2013		223,404		$	1.00
Exercisable – January 1, 2013		-		$	-
Granted		318,000		$	1.00
Exercised		-		$	-
Forfeited/Cancelled		-		$	-
Outstanding – December 31, 2013		541,404		$	1.00
Exercisable – December 31, 2013		428,845		$	1.00
Granted		-		$	-
Exercised		-		$	-
Forfeited/Cancelled		-		$	-
Outstanding – January 31, 2014		541,404		$	1.00
Exercisable – January 31, 2014		434,177		$	1.00
Granted		59,000		$	2.95
Exercised		-		$	-
Forfeited/Cancelled		(36,000	)	$	-
Outstanding – July 31, 2014		564,404		$	1.20
Exercisable – July 31, 2014		472,404		$	1.22

Summary of Option Outstanding and Exercisable

Options Outstanding							Options Exercisable
Range of Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

$	1.00		505,404	3.52 years	$	1.00		417,904	$	1.00
$	2.95		50,000	4.73 years	$	2.95		50,000	$	2.95
$	2.97		9,000	4.75 years	$	2.97		4,500	$	2.97

Schedule of Warrants Activity

The following is a summary of the Company’s warrant activity:

	Warrants		Weighted Average Exercise Price

Outstanding – January 1, 2013		505,400	$	1.00
Exercisable – January 1, 2013		-	$	-
Granted		386,667	$	1.50
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – December 31, 2013		892,067	$	1.22
Exercisable – December 31, 2013		892,067	$	1.22
Granted		30,000	$	1.50
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – January 31, 2014		922,067	$	1.22
Exercisable – January 31, 2014		922,067	$	1.22
Granted		189,334	$	2.02
Exercised		-	$	-
Forfeited/Cancelled		-	$	-
Outstanding – July 31, 2014		1,111,401	$	1.36
Exercisable – July 31, 2014		1,013,401	$	1.25

Schedule of Warrants Outstanding and Exercisable

Warrants Outstanding						Warrants Exercisable
Range of Exercise Price		Number Outstanding	Weighted Average Remaining Contractual Life (in years)	Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price

	$1.00-$2.50	1,111,401	3.71 years	$	1.36		1,013,401	$	1.25

Commitments and Contingencies (Tables)

6 Months Ended

Jul. 31, 2014

Commitments and Contingencies Disclosure [Abstract]

Schedule of Royalty Minimum Payment by Preceding Agreement Year

In order to continue the Exclusive term, the Company shall pay a minimum royalty with respect to the preceding Agreement year as follows:

Agreement Year	Minimum Royalty to be Paid with Respect to Such Agreement Year
1^stand 2^nd	$	-
3^rdand 4^th	$	50,000
5^th, 6^th and 7^th	$	75,000
8^thand 9^th	$	100,000
10^thand thereafter	$	125,000

Subsequent Events (Tables)

6 Months Ended

Jul. 31, 2014

Subsequent Events [Abstract]

Schedule of Line of Credit

The facility consists of the following:

●	Accounts Revolving Line of Credit:	$	2,150,000
●	Inventory Revolving Line of Credit:	$	350,000
●	Term Loan Line of Credit:	$	600,000

Nature of Operations and Basis of Presentation (Details Narrative)

Nature of Operations and Basis of Presentation (Details Narrative) (USD $)	0 Months Ended
	Jan. 24, 2013
Nature Of Operations And Basis Of Presentation
Number of shares issued in exchange for acquisition	20,054,000
Number of shares cancelled	103,408,000
Aggregate amount paid in cancellation to majority shareholders	$ 295,000
Stock issued for consideration of common stock cancellation for majority shareholders	800,000

Summary of Significant Accounting Policies (Details Narrative)

Summary of Significant Accounting Policies (Details Narrative) (USD $)	1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Jul. 31, 2014	Jun. 30, 2013
Accounting Policies [Abstract]
Cash equivalents	$ 0	$ 0		$ 0
Accounts receivable reserves	2,000	2,000		2,000
Stock offering cost recorded	102,166			321,194	0
Research and development expense	8,477	24,091	3,995	42,992	7,138
Advertising expenses	232,481	549,560	393,722	1,265,859	810,722
Share based compensation	45,681	248,982	156,104	348,081	156,104
Reduction in additional paid in capital				348,081	171,974
Assumption risk-free interest rate of option in effect at the time of the grant minimum				0.26%
Assumption risk-free interest rate of option in effect at the time of the grant maximum				17.60%
Expected common stock dividend rate				$ 0
Expected volatility rate, minimum				144.00%
Expected volatility rate, maximum				193.00%
Historical forfeiture rate for unvested stock option				0.00%

Summary of Significant Accounting Policies - Schedule of Inventories (Details)

Summary of Significant Accounting Policies - Schedule of Inventories (Details) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Accounting Policies [Abstract]
Finished goods	$ 469,158	$ 159,829

Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details)

Summary of Significant Accounting Policies - Schedule of Property and Equipment Estimated Useful Lives (Details)	6 Months Ended
	Jul. 31, 2014
Minimum [Member] \| Machinery And Equipment [Member]
Property and equipment estimated useful lives	2 years
Minimum [Member] \| Furniture And Fixtures [Member]
Property and equipment estimated useful lives	3 years
Minimum [Member] \| Leasehold Improvements [Member]
Property and equipment estimated useful lives	3 years
Maximum [Member] \| Machinery And Equipment [Member]
Property and equipment estimated useful lives	7 years
Maximum [Member] \| Furniture And Fixtures [Member]
Property and equipment estimated useful lives	5 years
Maximum [Member] \| Leasehold Improvements [Member]
Property and equipment estimated useful lives	10 years

Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction (Details)

Summary of Significant Accounting Policies - Schedule of Expenses of Slotting Fees and Sales Discount Accounted for Direct Revenue Reduction (Details) (USD $)	1 Months Ended	3 Months Ended		6 Months Ended
	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Jul. 31, 2014	Jun. 30, 2013
Accounting Policies [Abstract]
Gross Sales	$ 796,177			$ 5,021,325	$ 3,716,948
Less: Slotting, Discounts, Allowances	20,925			188,408	244,396
Net Sales	$ 775,252	$ 2,249,768	$ 1,700,388	$ 4,832,917	$ 3,472,552

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details)	Jul. 31, 2014	Jan. 31, 2014	Jun. 30, 2013
Accounting Policies [Abstract]
Common stock subscribed, shares	66,667	833,333
Common stock warrants	1,111,401		505,400
Common stock options	564,404		491,404
Total common stock equivalents	1,742,472		996,804

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) (Parenthetical)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents (Details) (Parenthetical) (USD $)	1 Months Ended	6 Months Ended		12 Months Ended
	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Dec. 31, 2013
Common stock warrants, exercise price range			$ 1.00
Common stock options, exercise price		$ 2.95	$ 1.00	$ 1.00
Minimum [Member]
Common stock warrants, exercise price range		$ 1.00
Common stock options, exercise price		$ 1.00
Maximum [Member]
Common stock warrants, exercise price range		$ 1.50
Common stock options, exercise price		$ 2.97

Property and Equipment (Details Narrative)

Property and Equipment (Details Narrative) (USD $)	1 Months Ended	3 Months Ended		6 Months Ended
Property and Equipment (Details Narrative) (USD $)	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Jul. 31, 2014	Jun. 30, 2013
Property, Plant and Equipment [Abstract]
Fixed assets amount	$ 826,340
Depreciation expense	$ 4,141	$ 44,736	$ 6,492	$ 59,473	$ 9,752

Property and Equipment - Schedule of Property Plant and Equipment (Details)

Property and Equipment - Schedule of Property Plant and Equipment (Details) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Property, Plant and Equipment [Abstract]
Machinery and Equipment	$ 1,034,943	$ 1,027,431
Furniture and Fixtures	14,672	4,525
Leasehold Improvements	208,814	2,733
Property Plant And Equipment, Gross	1,258,430	1,034,689
Less: Accumulated Depreciation	116,135	56,662
Property, plant and equipment, net	$ 1,142,295	$ 978,027

Investment in Meatball Obsession, LLC (Details Narrative)

Investment in Meatball Obsession, LLC (Details Narrative) (USD $)	0 Months Ended
	Dec. 31, 2011	Jul. 31, 2014 Meatball Obsession, LLC [Member]	Jun. 30, 2013 Meatball Obsession, LLC [Member]	Dec. 31, 2011 Meatball Obsession, LLC [Member]
Percentage of equity interest acquired in business combination				34.62%
Total investment in Meatball Obsession, LLC				$ 27,032
Reduction in investment due to losses in affiliates	$ 0
Reduction in ownership percentage		13.00%	24.00%

Related Party Transactions (Details Narrative)

Related Party Transactions (Details Narrative) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Related Party Transactions [Abstract]
Deposit in inventory with manufacturer	$ 1,220,221	$ 598,987

Related Party Transactions - Schedule of Amount Due from Manufacturer (Details)

Related Party Transactions - Schedule of Amount Due from Manufacturer (Details) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Related Party Transactions [Abstract]
Customer receipts collected by Manufacturer on behalf of Company	$ 575,255	$ 575,255
Loan to Manufacturer	450,000	450,000
Shared expenses paid by Manufacturer on behalf of the Company	(285,072)	(251,206)
Due from Manufacturer	$ 740,183	$ 774,049

Line of Credit (Details Narrative)

Line of Credit (Details Narrative) (USD $)	1 Months Ended	6 Months Ended
Line of Credit (Details Narrative) (USD $)	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Jul. 31, 2014 Secured Demand Credit Facility Backed By Receivables and Inventory [Member]	Jan. 03, 2014 Secured Demand Credit Facility Backed By Receivables and Inventory [Member]
Secured demand credit facility backed by its receivables and inventory					$ 1,500,000
Purchased eligible accounts receivables, percentage				70.00%
Percentage of reserve on purchased eligible accounts receivables				30.00%
Interest rate on advances or borrowings under the FGI Facility				The greater of (i) 6.75% per annum and (ii) 2.50% above the prime rate.
Collateral management fees, percentage of average monthly balance of Purchased Accounts				0.42%
Minimum monthly net funds employed during each contract year				500,000
One-time facility fee, percentage of credit facility upon entry into Sale and Security Agreement				1.00%
Additional fees and accrued interest paid	$ 8,640	$ 43,344	$ 3,775	$ 48,600

Concentrations (Details Narrative)

Concentrations (Details Narrative)	1 Months Ended	6 Months Ended
Concentrations (Details Narrative)	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013
Customer A [Member]
Concentrations of Revenues	18.00%	23.00%	23.00%
Percentage of accounts receivables	24.00%	21.00%
Customer B [Member]
Concentrations of Revenues	15.00%	17.00%	16.00%
Percentage of accounts receivables		13.00%
Customer C [Member]
Concentrations of Revenues	10.00%	11.00%	15.00%
Customer D [Member]
Concentrations of Revenues			10.00%
Customer E [Member]
Concentrations of Revenues			10.00%
Vendor One [Member]
Percentage of cost of sales during period	100.00%	100.00%	100.00%

Stockholders' Equity (Details Narrative)

Stockholders' Equity (Details Narrative) (USD $)	1 Months Ended		6 Months Ended		1 Months Ended
Stockholders' Equity (Details Narrative) (USD $)	Jul. 31, 2014	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Jun. 30, 2014 Investors [Member]	May 31, 2014 Investors [Member]	Apr. 30, 2014 Investors [Member]	Jan. 31, 2014 Investors [Member]	Mar. 31, 2013 Investors [Member]
Sold common shares					66,668	133,333	416,668	300,000	236,667
Common stock to investors in exchange			$ (1,180,003)		$ 100,000	$ 200,000	$ 625,001	$ 450,000	$ 355,000
Stock issuance costs relating to private placement					33,258	82,796	141,791	102,166	80,536
Stock issuance consisting cash					13,000	26,000	81,250	58,500	46,150
Number of warrants issued					8,667	17,333	41,667	30,000	23,667
Warrants issued for services					20,258	56,796	60,541	43,666	34,386
Total intrinsic value of options outstanding and exercisable	429,593	1,082,808	429,593
Weighted average expensing period of the unvested options			1 year 5 months 23 days
Share-based compensation	84,351	2,015	176,100	156,104
Total intrinsic value of warrants outstanding and exercisable	$ 607,390	$ 1,635,801	$ 607,390

Stockholders' Equity - Summary of Option Activity (Details)

Stockholders' Equity - Summary of Option Activity (Details) (USD $)	1 Months Ended	6 Months Ended		12 Months Ended
	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Dec. 31, 2013
Equity [Abstract]
Options Outstanding, Beginning balance	541,404	541,404	223,404	223,404
Options Exercisable, Beginning balance	428,845	434,177
Options, Granted		59,000		318,000
Options, Exercised
Options, Forfeited/Cancelled		(36,000)
Options Outstanding, Ending balance	541,404	564,404		541,404
Options Exercisable, Ending balance	434,177	472,404		428,845
Options Outstanding, Weighted Average Exercise Price, Beginning balance	$ 1.00	$ 1.00	$ 1.00	$ 1.00
Options Exercisable, Weighted Average Exercise Price, Beginning balance	$ 1.00	$ 1.00
Weighted Average Exercise Price, Granted		$ 2.95	$ 1.00	$ 1.00
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited/Cancelled
Options Outstanding, Weighted Average Exercise Price, Ending balance	$ 1.00	$ 1.20		$ 1.00
Options Exercisable, Weighted Average Exercise Price, Ending balance	$ 1.00	$ 1.22		$ 1.00

Stockholders' Equity - Summary of Option Outstanding and Exercisable (Details)

Stockholders' Equity - Summary of Option Outstanding and Exercisable (Details) (USD $)					6 Months Ended
	Jul. 31, 2014	Jan. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Jul. 31, 2014 Range Of Exercise Price One [Member]	Jul. 31, 2014 Range Of Exercise Price Two [Member]	Jul. 31, 2014 Range Of Exercise Price Three [Member]
Range of exercise price					$ 1.00	$ 2.95	$ 2.97
Number of Options Outstanding	564,404	541,404	541,404	223,404	505,404	50,000	9,000
Weighted Average Remaining Contractual Life (in years), Options Outstanding					3 years 6 months 7 days	4 years 8 months 23 days	4 years 9 months
Weighted Average Exercise Price, Options Outstanding	$ 1.20	$ 1.00	$ 1.00	$ 1.00	$ 1.00	$ 2.95	$ 2.97
Number of Options Exercisable	472,404	434,177	428,845		417,904	50,000	4,500
Weighted Average Exercise Price, Options Exercisable	$ 1.22	$ 1.00	$ 1.00		$ 1.00	$ 2.95	$ 2.97

Stockholders' Equity - Schedule of Warrants Activity (Details)

Stockholders' Equity - Schedule of Warrants Activity (Details) (USD $)	1 Months Ended	6 Months Ended	12 Months Ended
	Jan. 31, 2014	Jul. 31, 2014	Dec. 31, 2013
Equity [Abstract]
Warrants Outstanding, Beginning balance	892,067	922,067	505,400
Warrants Exercisable, Beginning balance	892,067	922,067
Warrants, Granted	30,000	189,334	386,667
Warrants, Exercised
Warrants, Forfeited/Cancelled
Warrants Outstanding, Ending balance	922,067	1,111,401	892,067
Warrants Exercisable, Ending balance	922,067	1,013,401	892,067
Warrants Outstanding, Weighted Average Exercise Price, Beginning balance	$ 1.22	$ 1.22	$ 1.00
Warrants Exercisable, Weighted Average Exercise Price, Beginning balance	$ 1.22	$ 1.22
Weighted Average Exercise Price, Granted	$ 1.50	$ 2.02	$ 1.50
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Forfeited/Cancelled
Warrants Outstanding, Weighted Average Exercise Price, Ending balance	$ 1.22	$ 1.36	$ 1.22
Warrants Exercisable, Weighted Average Exercise Price, Ending balance	$ 1.22	$ 1.25	$ 1.22

Stockholders' Equity - Schedule of Warrants Outstanding and Exercisable (Details)

Stockholders' Equity - Schedule of Warrants Outstanding and Exercisable (Details) (USD $)	6 Months Ended
	Jul. 31, 2014	Jan. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Equity [Abstract]
Range of exercise price, lower limit	$ 1.00
Range of exercise price, higher limit	$ 2.50
Number of Warrants Outstanding	1,111,401
Weighted Average Remaining Contractual Life (in Years)	3 years 8 months 16 days
Weighted Average Exercise Price, Warrants Outstanding	$ 1.36
Number of Warrants Exercisable	1,013,401	922,067	892,067
Weighted Average Exercise Price, Warrants Exercisable	$ 1.25	$ 1.22	$ 1.22

Commitments and Contingencies (Details Narrative)

Commitments and Contingencies (Details Narrative) (USD $)	1 Months Ended	3 Months Ended		6 Months Ended		0 Months Ended	12 Months Ended	0 Months Ended	12 Months Ended	0 Months Ended	12 Months Ended		1 Months Ended	6 Months Ended
	Jan. 31, 2014	Jul. 31, 2014	Jun. 30, 2013	Jul. 31, 2014	Jun. 30, 2013	Dec. 01, 2011 Advisory Agreement One [Member]	Dec. 31, 2012 Advisory Agreement One [Member] Spartan Capital Securities, LLC [Member]	May 02, 2013 Advisory Agreement Two [Member]	Dec. 31, 2013 Advisory Agreement Two [Member] Spartan Capital Securities, LLC [Member]	Oct. 22, 2013 Advisory Agreement Three [Member]	Dec. 31, 2013 Advisory Agreement Three [Member] Spartan Capital Securities, LLC [Member]	Oct. 22, 2013 Advisory Agreement Three [Member] Spartan Capital Securities, LLC [Member]	Jan. 31, 2014 Advisory Agreement Four [Member] Spartan Capital Securities, LLC [Member]	Jul. 31, 2014 Advisory Agreement Five [Member] Spartan Capital Securities, LLC [Member]	Jul. 31, 2014 Year 1 [Member]	Jul. 31, 2014 Year 2 [Member]	Jul. 31, 2014 Year 2 [Member] Minimum [Member]	Jul. 31, 2014 Year 2 [Member] Maximum [Member]	Jul. 31, 2014 Year 3 [Member]	Jul. 31, 2014 Year 3 [Member] Minimum [Member]	Jul. 31, 2014 Year 3 [Member] Maximum [Member]	Jul. 31, 2014 Year 4 [Member]
Percentage of royalty rate on net sales															6.00%	4.00%			2.00%			1.00%
Royalty net sales															$ 500,000		$ 500,000	$ 2,500,000		$ 2,500,000	$ 20,000,000	$ 20,000,000
Royalty expenses	35,551	37,096	47,006	115,726	118,122
Proceeds from private placements						6,000,000		5,000,000		2,500,000
Percentage of fee equal to aggregate gross proceeds						10.00%		10.00%	3.00%	10.00%	3.00%
Percentage of common stock issuable						10.00%		10.00%		10.00%
Payment of maximum amount paid for consideration of expenses incurred by Spartan							40,000		10,000		10,000
Spartan fee paid amount							505,400		650,000		104,000		58,500	166,400
Number of warrants issued							505,400		333,333		53,333		30,000	91,333
Warrants Remaining Contractual Life							5 years		5 years		5 years		5 years	5 years
Warrants exercise price							$ 1.00		$ 1.50			$ 1.50	$ 1.50	$ 1.50
Spartan advisory agreement description								The Company shall pay to Spartan a non-refundable monthly fee of $10,000 over a twelve to twenty four month period upon Spartan’s satisfaction of certain thresholds (raising of aggregate gross proceeds of $4.0 mil- $5.0 mil) outlined in the Spartan Advisory Agreement.
Fees cancellation on agreement amendment									$ 10,000

Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details)

Commitments and Contingencies - Schedule of Royalty Minimum Payment by Preceding Agreement Year (Details) (USD $)	6 Months Ended
	Jul. 31, 2014
Agreement Year 1st and 2nd [Member]
Minimum Royalty to be Paid
Agreement Year 3rd and 4th [Member]
Minimum Royalty to be Paid	50,000
Agreement Year 5th, 6th and 7th [Member]
Minimum Royalty to be Paid	75,000
Agreement Year 8th and 9th [Member]
Minimum Royalty to be Paid	100,000
Agreement Year 10th and thereafter [Member]
Minimum Royalty to be Paid	$ 125,000

Subsequent Events (Details Narrative)

Subsequent Events (Details Narrative) (Growth Capital LLC [Member], Subsequent Event [Member], USD $)	0 Months Ended
	Sep. 03, 2014
Loan And Security Agreement One [Member]
Line of credit aggregate value	$ 3,100,000
Line of credit interest rate description	Generally reported by Citibank, N.A. plus (a) 2.5% on loans and advances made against eligible accounts and (b) 4.0% on loans made against eligible inventory. The term loan bears interest at a rate of the highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0%.
Line of credit annual facility percentage	2.25%
Line of credit default stated rates of interest	10.00%
Loan And Security Agreement Two [Member]
Line of credit aggregate value	600,000
Line of credit interest rate description	The Note bears interest at highest prime rate in effect during each month as generally reported by Citibank, N.A. plus 4.0% and is payable monthly.
Line of credit default stated rates of interest	10.00%
Term of loan	5 years
Note payable, duration	60 months
Note payable, monthly installments amount	$ 10,000

Subsequent Events - Schedule of Line of Credit (Details)

Subsequent Events - Schedule of Line of Credit (Details) (Line of Credit [Member], Subsequent Event [Member], USD $)	Sep. 03, 2014
Line of Credit [Member] \| Subsequent Event [Member]
Accounts Revolving Line of Credit:	$ 2,150,000
Inventory Revolving Line of Credit:	350,000
Term Loan Line of Credit:	$ 600,000